Literature DB >> 6840162

Acute haemodynamic effects of a single intravenous dose of piretanide in congestive heart failure.

H Valette, J L Hébert, E Apoil.   

Abstract

The haemodynamic effect of a single 12 mg intravenous dose of piretanide was assessed in 11 patients with congestive heart failure. It did not cause any change in cardiac output, heart rate or systemic vascular resistance, whereas the pulmonary wedge, mean pulmonary and right atrial pressures and pulmonary blood volume fell progressively, the difference from the control values being significant 5 minutes after the injection. The temporal evolution of the ratios pulmonary wedge pressure/total blood volume, pulmonary blood volume/total blood volume, right atrial pressure/total blood volume was chiefly determined by the numerator, which in all cases showed a more rapid decrease than total blood volume. Serum electrolytes remained unchanged 1 hour after the injection of the drug, except for potassium which fell from 4.9 to 4.1 mEq/l, while urinary sodium and potassium excretion were greatly increased. This high ceiling diuretic appears to have renal and venodilator properties close to those of furosemide.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6840162     DOI: 10.1007/bf00613811

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  17 in total

1.  Blood volume measurements with a new instrument.

Authors:  J A BUCKWALTER; J L FERGUSON; R J JOHNSON; R T SOPER
Journal:  Arch Surg       Date:  1963-05

2.  Evaluation of a new cuvette densitometer for determination of cardiac output.

Authors:  O W SHADLE; T B FERGUSON; D E GREGG; S R GILFORD
Journal:  Circ Res       Date:  1953-05       Impact factor: 17.367

3.  [Gamma function extrapolation of dilution curves for pulmonary blood volume determination in chronic bronchitis (author's transl)].

Authors:  J Polianski; H Valette; J Mensch-Dechène; D Allouche; A Lockhart
Journal:  Bull Eur Physiopathol Respir       Date:  1977 Sep-Oct

4.  Combined therapy with vasodilator drugs and beta-adrenergic blockade in hypertension. A comparative study of minoxidil and hydralazine.

Authors:  T B Gottlieb; F H Katz; C A Chidsey
Journal:  Circulation       Date:  1972-03       Impact factor: 29.690

5.  Hemodynamic effects of ethacrynic acid in anephric dogs.

Authors:  R I Ogilvie; J Ruedy
Journal:  J Pharmacol Exp Ther       Date:  1971-02       Impact factor: 4.030

6.  Plethysmographic study with frusemide and piretanide in healthy volunteers.

Authors:  H Valette; P Duhaze; E Apoil
Journal:  Br J Clin Pharmacol       Date:  1979-02       Impact factor: 4.335

7.  Comparison of hemodynamic effects of furosemide and piretanide in normovolemic patients.

Authors:  H Valette; J L Hebert; B Raffestin; A Lockhart; E Apoil
Journal:  J Cardiovasc Pharmacol       Date:  1980       Impact factor: 3.105

8.  Kinetic and dynamic comparison of piretanide and furosemide.

Authors:  J R Lawrence; A F Ansari; H L Elliott; D J Sumner; G F Brunton; B Whiting; R Whitesmith
Journal:  Clin Pharmacol Ther       Date:  1978-05       Impact factor: 6.875

9.  The acute hemodynamic effects of ethacrynic acid and furosemide in patients with chronic postcapillary pulmonary hypertension.

Authors:  S M Austin; B F Schreiner; D H Kramer; P M Shah; P N Yu
Journal:  Circulation       Date:  1976-02       Impact factor: 29.690

10.  A single dose comparison of piretanide and bumetanide in congestive cardiac failure.

Authors:  M Homeida; C J Roberts; S L Dombey
Journal:  Br J Clin Pharmacol       Date:  1979-08       Impact factor: 4.335

View more
  3 in total

Review 1.  Central hemodynamic effects of diuretic therapy in chronic heart failure.

Authors:  B Silke
Journal:  Cardiovasc Drugs Ther       Date:  1993-01       Impact factor: 3.727

Review 2.  Acute and long term effects of loop diuretics in heart failure.

Authors:  F Krück
Journal:  Drugs       Date:  1991       Impact factor: 9.546

Review 3.  Piretanide. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

Authors:  S P Clissold; R N Brogden
Journal:  Drugs       Date:  1985-06       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.